Oxford Covid biotech firm makes stellar debut on London stock market
Shares of Oxford Nanopore close up 44%, giving co-founder paper fortune of £63mSee all our coronavirus coverageOxford Nanopore, whose DNA sequencing technology has been essential in tracking Covid-19 variants globally, has made a stellar stock market debut in London. A rise in its share price of as much as 47% has left the firm valued at almost £5bn.The flotation of the Oxford University spin-out has given its chief executive and co-founder, Gordon Sanghera, a fortune on paper of £63m.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 30, 2021 Category: Science Authors: Julia Kollewe Tags: IPOs FTSE Stock markets Nanotechnology Biochemistry and molecular biology Science University of Oxford Business UK news Source Type: news
Bristol retains Strategic Partnership with the BBSRC and ranks fourth for bioscience research funding
The BBSRC, one of the UK ’ s largest UK bioscience funders, has announced Bristol will retain its Strategic Partnership (SP) status. The decision was announced this month following BBSRC ’ s SP member triannual review. Bristol is one of only ten top-funded university partners with this status – which it has retained since 2012 recognising the University ’ s long-term record for excellence in biosciences research. (Source: University of Bristol news)
Source: University of Bristol news - September 30, 2021 Category: Universities & Medical Training Tags: Grants and Awards, Business and Enterprise, Research; Faculty of Life Sciences, Faculty of Life Sciences, School of Biological Sciences, Faculty of Life Sciences, School of Biochemistry, Faculty of Life Sciences, School of Cellular and Molecular Medicine, Source Type: news
Antibodies in breast milk remain for 10 months after Covid infection – study
Exclusive: Researchers believe such antibodies could be used to treat people with severe coronavirusCoronavirus – latest updatesSee all our coronavirus coverageBreastfeeding women who have been infected with Covid-19 continue to secrete virus-neutralising antibodies into their milk for up to 10 months, data suggests.Besides emphasising the important role breastfeeding could play in helping to protect infants from the disease, researchers believe that such antibodies could be used to treat people with severe Covid-19, preventing their condition from getting worse.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 27, 2021 Category: Science Authors: Linda Geddes Tags: Breastfeeding Coronavirus Science Infectious diseases Microbiology Immunology World news Medical research Biochemistry and molecular biology Source Type: news
Major advance in race for SARS-CoV-2 inhibitor drugs
A new advance towards the development of drugs specifically designed to inhibit a key SARS-CoV-2 enzyme is reported in the Royal Society of Chemistry's leading journal, Chemical Science. The international team, led by scientists from the Universities of Oxford and Bristol, has designed new peptide molecules and shown that they block (inhibit) the virus ’ s main protease [Mpro] - a prominent SARS-CoV-2 drug target. (Source: University of Bristol news)
Source: University of Bristol news - September 20, 2021 Category: Universities & Medical Training Tags: International, Research; Faculty of Science, Faculty of Science, School of Chemistry, Faculty of Life Sciences, Faculty of Life Sciences, School of Biochemistry; Press Release Source Type: news
Oxford Covid biotech firm plans £2.4bn flotation on LSE
Business founded in 2005 has won contracts worth £144m from the UK government during pandemicOxford Nanopore, whose Covid-19 technology wassnapped up by the UK government and used to track variants of the virus globally, has unveiled its plans to float in one of the biggest London debuts this year.The company, a startup spun out from Oxford University, hopes to exceed a £2.4bn valuation achieved at a fundraising round in May. It has laid out plans to tap into the growing genomic sequencing market, estimated to be worth $5.7bn globally. Its revenues more than doubled to £114m last year, from £52m in 2019. It is aiming t...
Source: Guardian Unlimited Science - September 9, 2021 Category: Science Authors: Julia Kollewe Tags: IPOs Biochemistry and molecular biology Coronavirus Nanotechnology University of Oxford Business Stock markets Science Infectious diseases Source Type: news
Neuroscience and the misperception of reality | Letter
As living creatures, we are exquisitely evolved to interact with the world through perception, saysDavid HughesGaia Vince, reviewing Anil Seth ’s Being You: A New Science of Consciousness (The exhilarating new science of consciousness, 25 August), extols the thesis that because our perception of the world is a complex physical process, perception is itself a “hallucination” and “a big lie created by our deceptive brains”. But when we consider that dogs hear sounds we don’t, flies look through compound eyes, birds navigate using inbuilt GPS, it does seem perverse to claim that the very physicality of being alive...
Source: Guardian Unlimited Science - September 3, 2021 Category: Science Authors: Letters Tags: Neuroscience Psychology Science and nature books Consciousness Source Type: news
Edmond Fischer, Biochemist and Nobel Laureate, Dies at 101
Fischer was recognized for his work with reversible protein phosphorylation. (Source: The Scientist)
Source: The Scientist - August 31, 2021 Category: Science Tags: News & Opinion Source Type: news
Henry Higgs Named the John La Porte Given Professor in Cytology
Henry N. Higgs, PhD, a nationally known researcher and professor of biochemistry and cell biology at Dartmouth’s Geisel School of Medicine, has been named the John La Porte Given Professor in Cytology. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - August 11, 2021 Category: Hospital Management Authors: Timothy Dean Tags: News Henry Higgs professorship Source Type: news
Community-acquired bacterial meningitis
Progress has been made in the prevention and treatment of community-acquired bacterial meningitis during the past three decades but the burden of the disease remains high globally. Conjugate vaccines against the three most common causative pathogens (Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae) have reduced the incidence of disease, but with the replacement by non-vaccine pneumococcal serotypes and the emergence of bacterial strains with reduced susceptibility to antimicrobial treatment, meningitis continues to pose a major health challenge worldwide. In patients presenting with bacterial m...
Source: Current Awareness Service for Health (CASH) - July 28, 2021 Category: Consumer Health News Source Type: news
A.I. Predicts the Shapes of Molecules to Come
DeepMind has given 3-D structure to 350,000 proteins, including every one made by humans, promising a boon for medicine and drug design. (Source: NYT Health)
Source: NYT Health - July 22, 2021 Category: Consumer Health News Authors: Cade Metz Tags: Proteins Artificial Intelligence Computers and the Internet Genetics and Heredity Biology and Biochemistry Human Genome Project your-feed-science your-feed-health Source Type: news
Revolutionary mosquito researchers receive $2.7 million grant
(Virginia Tech) " Mosquitoes are sometimes described as the deadliest animal on Earth, " said Cl é ment Vinauger, principal investigator on the project and assistant professor from the Department of Biochemistry in the College of Agriculture and Life Sciences. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 16, 2021 Category: International Medicine & Public Health Source Type: news
Thomas Rando named director of UCLA Broad Stem Cell Research Center
Dr. Thomas Rando, a renowned neurologist and stem cell biologist, has been named director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA.Rando, who was chosen after an international search, is currently a professor of neurology and neurological sciences at the medical school at Stanford University, where he also serves as director of the Glenn Center for the Biology of Aging and deputy director of the Stanford Center on Longevity. In addition, he is chief of neurology at the Veterans Affairs Palo Alto Health Care System.His appointment is effective Oct. 1.“As a trailblazi...
Source: UCLA Newsroom: Health Sciences - July 7, 2021 Category: Universities & Medical Training Source Type: news
Gambia: Upstate Faculty Member Named As a Pew Scholar in Biomedical Sciences
[The Point] Alaji Bah, PhD, assistant professor in the Department of Biochemistry and Molecular Biology at Upstate Medical University has been named as a 2021 Pew Scholar in the Biomedical Sciences, the Pew Charitable Trusts announced. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 7, 2021 Category: African Health Source Type: news
NIDCR's Summer 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page.
NIDCR's Summer 2021 E-Newsletter
In this issue:
NIDCR News
Funding Opportunities & Related Notices
NIH/HHS News
Subscribe to NICDR News
Science Advances
Grantee News
NIDCR News
NIDCR to Release Report on Oral Health in America
As a 20-year follow-up to the seminal Oral Health in America: A Report of the Surgeon General, NIDCR will release Oral Health in America: Advances and Challenges in the fall of 2021. The report will illuminate new directions in the prevention an...
Source: NIDCR Science News - July 1, 2021 Category: Dentistry Source Type: news
